Frequency of isolation and antimicrobial susceptibility of bacteria isolated from bloodstream infections at Children's Medical Center, Tehran, Iran, 1996-2000

International Journal of Antimicrobial Agents

Volumn 26, Issue 5, 2005, Pages 373-379

  Mamishi, Setareh ^a   Pourakbari, Babak ^a   Ashtiani, Mohammad H ^b   Hashemi, Farhad B ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antimicrobial susceptibility; Bloodstream infections; Iran

Indexed keywords

AMIKACIN; AMPICILLIN; CEFALEXIN; CEFALOTIN; CEFAZOLIN; CEFTIZOXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; KANAMYCIN; OXACILLIN; PENICILLIN G; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD CULTURE; BLOOD FLOW; BLOOD SAMPLING; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG SENSITIVITY; ENTEROCOCCUS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH PROGRAM; HUMAN; IRAN; KLEBSIELLA; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TIME SERIES ANALYSIS;

BACTEREMIA; BACTERIA; CHILD; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; IRAN; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES;

EID: 26944502744     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2005.08.004     Document Type: Article

References (38)

1. D.J. Dikekema, S.E. Beekmann, K.C. Chapin, K.A. Morel, E. Munson, and G.V. Doern Epidemiology and outcome of nosocomial and community-onset bloodstream infection J Clin Microbiol 41 2003 3655 3660
2. D. Pittet, N. Li, R.F. Woolson, and R.P. Wenzel Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model Clin Infect Dis 24 1997 1068 1078
3. M.P. Weinstein, L.B. Reller, J.R. Murray, and K.A. Lichtenstein The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. Laboratory and epidemiologic observations Rev Infect Dis 5 1983 35 53
4. American Society for Microbiology Report of the ASM Task Force on Antibiotic Resistance. Antimicrob Agents Chemother 1995;Suppl:1-23.
5. Nosocomial infection rates for interhospital comparison: limitations and possible solutions. A Report from the National Nosocomial Infections Surveillance (NNIS) System. Infect Control Hosp Epidemiol 1991;12:609-21.
6. M.P. Weinstein, M.L. Towns, and S.M. Quartey The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults Clin Infect Dis 24 1997 584 602
7. Centers for Disease Control and Prevention. CDC's campaign to prevent antimicrobial resistance in health-care settings. MMWR Morb Mortal Wkly Rep 2002;51:343.
8. D.J. Diekema, M.A. Pfaller, and R.N. Jones Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY antimicrobial surveillance program, 1997 Clin Infect Dis 29 1999 595 607
9. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1997, issued May 1997. Am J Infect Control 1997;25:477-87.
10. M. Pezzlo Aerobic bacteriology H.D. Isenberg Clinical microbiology procedures handbook 1992 American Society for Microbiology Washington, DC 1.19.1 1.20.47
11. S.B. Reisner, G.L. Woods, R.P. Thomson, D.H. Larone, L.S. Garcia, and R.Y. Shimuzu Specimen collection P.R. Murray E.J. Baron M.A. Pfaller F.C. Tenover R.H. Yolken Manual of clinical microbiology 7th ed. 1999 American Society for Microbiology Washington, DC 64 76
12. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A4. Wayne, PA: NCCLS; 1997.
13. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved Standard M2-A6. Wayne, PA: NCCLS; 1997.
14. A.C. Fluit, M.E. Jones, F.J. Schmitz, J. Acar, R. Gupta, and J. Verhoef Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998 Clin Infect Dis 30 2000 454 460
15. Diekema DJ, Pfaller MA, Jones RN, et al. Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group. Int J Antimicrob Agents 2000;13:257-71.
16. C. Von Eiff, K. Becker, K. Machka, H. Stammer, and G. Peters Nasal carriage as a source of Staphylococcus aureus bacteraemia N Engl J Med 344 2001 11 16
17. J.A. Karlowsky, M.E. Jones, D.C. Draghi, C. Thornsberry, D.F. Sahm, and G.A. Volturo Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002 Ann Clin Microbiol Antimicrob 3 2004 7 14
18. M.A. Pfaller, R.N. Jones, and S.A. Marshall Inducible Amp-C β-lactamase producing Gram-negative bacilli from bloodstream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE) Diagn Microbiol Infect Dis 28 1997 211 219
19. Decousser JW, Pina P, Picot F, et al.; ColBVH study group. Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: a French prospective national survey. J Antimicrob Chemother 2003;51:1213-22.
20. Pfaller MA, Jones RN, Doern GV, Kugler K; SENTRY Participant Group. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada) 1997. Antimicrob Agents Chemother 1998;42:1762-70.
21. F.J. Schmitz, E. Lindenlauf, B. Hofmann, and A.C. Fluit The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals J Antimicrob Chemother 42 1998 489 495
22. A. El Kholy, H. Baseem, G.S. Hall, G.W. Procop, and D.L. Longworth Antimicrobial resistance in Cairo, Egypt 1999-2000: a survey of five hospitals J Antimicrob Chemother 51 2003 625 630
23. W. Hryniewicz, T. Zareba, and M. Kawalec Susceptibility patterns of Enterococcus spp. isolated in Poland during 1996 Int J Antimicrob Agents 10 1998 303 307
24. M.M. Feizabadi, S. Asadi, and A. Aliahmadi Drug resistant patterns of enterococci recovered from patients in Tehran during 2000-2003 Int J Antimicrob Agents 24 2004 521 522
25. D.E. Low, N. Keller, A. Barth, and R.N. Jones Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999 Clin Infect Dis 32 2001 S133 S145
26. H.M. Aucken, M. Warner, and M. Ganner Twenty months of screening for glycopeptide-intermediate Staphylococcus aureus J Antimicrob Chemother 46 2000 639 645
27. R. Geisel, F.J. Schmitz, and L. Thomas Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus in the Düsseldorf area J Antimicrob Chemother 43 1999 846 848
28. C.M. Tobin, J.M. Darville, and A.H. Thomson Vancomycin therapeutic drug monitoring: is there a consensus view? The results of a UK National External Quality Assessment Scheme (UK NEQAS) for Antibiotic Assays questionnaire J Antimicrob Chemother 50 2002 713 718
29. S.L. Kaplan, and E.O. Mason Jr. Management of infections due to antibiotic-resistant Streptococcus pneumoniae Clin Microbiol Rev 11 1998 628 644
30. P.L. Winokur, R. Canton, J.M. Casellas, and N. Legakis Variations in the prevalence of strains expressing an extended spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region Clin Infect Dis 32 Suppl. 2001 S94 S103
31. A.C. Gales, R.N. Jones, K.R. Forward, J. Linares, H.S. Sader, and J. Verhoef Emerging importance of multi-drug resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999) Clin Infect Dis 32 Suppl. 2001 S104 S113
32. C.P. Oplustil, R. Nunes, and C. Mendes Multicenter evaluation of resistance patterns of Klebsiella pneumoniae, Escherichia coli, Salmonella spp., and Shigella spp. isolated from clinical specimens in Brazil: RESISTNET Surveillance Program Braz J Infect Dis 5 2001 8 12
33. Issaragrisil S, Kaufman DW, Anderson T, et al. Low drug attributability of aplastic anemia in Thailand. The Aplastic Anemia Study Group. Blood 1997;89:4034-9.
34. H.M. Feder Jr. Chloramphenicol: what we have learned in the last decade South Med J 79 1986 1129 1134
35. Jones RN, Pfaller MA, Doern GV, Erwin ME, Hollis RJ. Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group. Diagn Microbiol Infect Dis 1998;30:215-28.
36. D.M. Johnson, D.J. Bieddenbach, and R.N. Jones Potency and antimicrobial spectrum update for piperacillin/tazobactam: emphasis on its activity against resistant organism populations and generally untested species causing community acquired respiratory tract infections Diagn Microbiol Infect Dis 43 2002 49 60
37. A.C. Gales, A. Bolmstrom, J. Sampaio, and H.S. Sader Antimicrobial susceptibility of Klebsiella pneumoniae producing extended spectrum β-lactamase (ESBL) isolated in hospitals in Brazil Braz J Infect Dis 1 1997 196 203
38. L. Archibald, L. Phillips, D. Monnet, J.E. McGowan, F. Tenover, and R. Gaynes Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit Clin Infect Dis 24 1997 211 215